Shoubin Zhan

887 total citations
15 papers, 522 citations indexed

About

Shoubin Zhan is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Shoubin Zhan has authored 15 papers receiving a total of 522 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Cancer Research and 5 papers in Immunology. Recurrent topics in Shoubin Zhan's work include Extracellular vesicles in disease (6 papers), MicroRNA in disease regulation (5 papers) and RNA modifications and cancer (4 papers). Shoubin Zhan is often cited by papers focused on Extracellular vesicles in disease (6 papers), MicroRNA in disease regulation (5 papers) and RNA modifications and cancer (4 papers). Shoubin Zhan collaborates with scholars based in China, Czechia and Pakistan. Shoubin Zhan's co-authors include Xi Chen, Huanhuan Hu, Fangfang Jin, Yanbo Wang, Hongwei Liang, Xi Chen, Hong Shen, Gaoli Liang, Geyu Zhou and Chenyu Zhang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Scientific Reports.

In The Last Decade

Shoubin Zhan

14 papers receiving 519 citations

Peers

Shoubin Zhan
Sisi Wei China
Caiguo Ye China
Yan Zou China
José Manuel Lerma-Díaz Mexico
Xiaoying Zhao China
Ji Hyo Lyu South Korea
Cong Niu China
Omar Rahal United States
Guomin Zhang China
Sisi Wei China
Shoubin Zhan
Citations per year, relative to Shoubin Zhan Shoubin Zhan (= 1×) peers Sisi Wei

Countries citing papers authored by Shoubin Zhan

Since Specialization
Citations

This map shows the geographic impact of Shoubin Zhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shoubin Zhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shoubin Zhan more than expected).

Fields of papers citing papers by Shoubin Zhan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shoubin Zhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shoubin Zhan. The network helps show where Shoubin Zhan may publish in the future.

Co-authorship network of co-authors of Shoubin Zhan

This figure shows the co-authorship network connecting the top 25 collaborators of Shoubin Zhan. A scholar is included among the top collaborators of Shoubin Zhan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shoubin Zhan. Shoubin Zhan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Wang, Zhongyu, Wenjing Liu, Xiaoshan Zhang, et al.. (2025). Machine Learning-Based Identification of Novel Exosome-Derived Metabolic Biomarkers for the Diagnosis of Systemic Lupus Erythematosus and Differentiation of Renal Involvement. Current Medical Science. 45(2). 231–243. 1 indexed citations
2.
Zhan, Shoubin, Ye Xu, Botao Li, et al.. (2025). Landscape of extracellular small RNA and identification of biomarkers in multiple human cancers. iScience. 28(8). 113098–113098.
3.
Bai, Ming, Tianyao Liu, Shoubin Zhan, et al.. (2025). Plasma tsRNA Signatures Serve as a Novel Biomarker for Bladder Cancer. Cancer Science. 116(5). 1255–1267. 4 indexed citations
4.
Yu, Lingfeng, Gentao Fan, Qingyan Wang, et al.. (2023). In vivo self-assembly and delivery of VEGFR2 siRNA-encapsulated small extracellular vesicles for lung metastatic osteosarcoma therapy. Cell Death and Disease. 14(9). 626–626. 12 indexed citations
5.
Hu, Huanhuan, Rongjie Cheng, Yanbo Wang, et al.. (2022). Oncogenic KRAS signaling drives evasion of innate immune surveillance in lung adenocarcinoma by activating CD47. Journal of Clinical Investigation. 133(2). 71 indexed citations
6.
Zhan, Shoubin, Ping Yang, Ye Xu, et al.. (2022). Serum mitochondrial tsRNA serves as a novel biomarker for hepatocarcinoma diagnosis. Frontiers of Medicine. 16(2). 216–226. 35 indexed citations
7.
Li, Tianhang, Zihan Zhao, Shoubin Zhan, et al.. (2022). The Lymph Node Microenvironment May Invigorate Cancer Cells With Enhanced Metastatic Capacities. Frontiers in Oncology. 12. 816506–816506. 6 indexed citations
8.
Wang, Zhen, Gentao Fan, Lingfeng Yu, et al.. (2022). PLOD2 high expression associates with immune infiltration and facilitates cancer progression in osteosarcoma. Frontiers in Oncology. 12. 980390–980390. 12 indexed citations
9.
Li, Tianhang, Zihan Zhao, Yuchen Pan, et al.. (2022). Antifungal immunity mediated by C-type lectin receptors may be a novel target in immunotherapy for urothelial bladder cancer. Frontiers in Immunology. 13. 911325–911325. 10 indexed citations
10.
Liu, Tianyao, Tianhang Li, Yufeng Zheng, et al.. (2022). Evaluating adipose‐derived stem cell exosomes as miRNA drug delivery systems for the treatment of bladder cancer. Cancer Medicine. 11(19). 3687–3699. 40 indexed citations
11.
Wang, Yanbo, Zhang‐Peng Chen, Huanhuan Hu, et al.. (2021). Sperm microRNAs confer depression susceptibility to offspring. Science Advances. 7(7). 78 indexed citations
12.
Zhan, Shoubin, Yanbo Wang, & Xi Chen. (2020). RNA virus-encoded microRNAs: biogenesis, functions and perspectives on application. PubMed. 2(1). 15–15. 16 indexed citations
13.
Wang, Yanbo, Hongwei Liang, Fangfang Jin, et al.. (2019). Injured liver-released miRNA-122 elicits acute pulmonary inflammation via activating alveolar macrophage TLR7 signaling pathway. Proceedings of the National Academy of Sciences. 116(13). 6162–6171. 59 indexed citations
14.
15.
Jin, Fangfang, Huanhuan Hu, Ming Xu, et al.. (2018). Serum microRNA Profiles Serve as Novel Biomarkers for Autoimmune Diseases. Frontiers in Immunology. 9. 2381–2381. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sisi Wei Breakdown of academic impact, for papers by Caiguo Ye Breakdown of academic impact, for papers by Yan Zou Breakdown of academic impact, for papers by José Manuel Lerma-Díaz Breakdown of academic impact, for papers by Xiaoying Zhao Breakdown of academic impact, for papers by Ji Hyo Lyu Breakdown of academic impact, for papers by Cong Niu Breakdown of academic impact, for papers by Omar Rahal Breakdown of academic impact, for papers by Guomin Zhang
Rankless by CCL
2026